Limits...
In Vitro and In Vivo Evaluation of Oxatomide β -Cyclodextrin Inclusion Complex.

Hashem FM, Mostafa M, Shaker M, Nasr M - J Pharm (Cairo) (2012)

Bottom Line: The coevaporated complex prepared in presence of PVP-K15 showed a prompt drug release and significantly increased % dissolution efficiency (P < 0.05) compared to the pure oxatomide.Moreover, the results of bioavailability evaluation of this complex in rabbits compared to commercial drug product indicated a 73.15% increase in the oral bioavailability of oxatomide.In conclusion, inclusion complex of oxatomide with β-cyclodextrin prepared by coevaporation in presence of PVP-K15 not only results in an enhancement of the oxatomide dissolution rate but also improves the bioavailability of oxatomide.

View Article: PubMed Central - PubMed

Affiliation: Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Helwan University, Cairo 11790, Egypt.

ABSTRACT
The objective of this study was to evaluate the influence of oxatomide β-cyclodextrin inclusion complex on the physicochemical properties and bioavailability of the drug. Oxatomide β-cyclodextrin solid complex was prepared with equimolar ratio of both oxatomide and β-cyclodextrin in presence or absence of water soluble polymers using different techniques. The coevaporated complex prepared in presence of PVP-K15 showed a prompt drug release and significantly increased % dissolution efficiency (P < 0.05) compared to the pure oxatomide. Moreover, the results of bioavailability evaluation of this complex in rabbits compared to commercial drug product indicated a 73.15% increase in the oral bioavailability of oxatomide. In conclusion, inclusion complex of oxatomide with β-cyclodextrin prepared by coevaporation in presence of PVP-K15 not only results in an enhancement of the oxatomide dissolution rate but also improves the bioavailability of oxatomide.

No MeSH data available.


Related in: MedlinePlus

Dissolution profiles of oxatomide powder and corresponding β-cyclodextrin inclusion complexes in distilled water (pH 6.8).
© Copyright Policy - open-access
Related In: Results  -  Collection


getmorefigures.php?uid=PMC4595936&req=5

fig5: Dissolution profiles of oxatomide powder and corresponding β-cyclodextrin inclusion complexes in distilled water (pH 6.8).

Mentions: As illustrated in Figure 5, it is clear that all inclusion complexes prepared by coevaporation, spray drying, and freeze drying exhibited higher dissolution characteristics than kneaded mixture, physical mixture, and pure oxatomide in distilled water.


In Vitro and In Vivo Evaluation of Oxatomide β -Cyclodextrin Inclusion Complex.

Hashem FM, Mostafa M, Shaker M, Nasr M - J Pharm (Cairo) (2012)

Dissolution profiles of oxatomide powder and corresponding β-cyclodextrin inclusion complexes in distilled water (pH 6.8).
© Copyright Policy - open-access
Related In: Results  -  Collection

Show All Figures
getmorefigures.php?uid=PMC4595936&req=5

fig5: Dissolution profiles of oxatomide powder and corresponding β-cyclodextrin inclusion complexes in distilled water (pH 6.8).
Mentions: As illustrated in Figure 5, it is clear that all inclusion complexes prepared by coevaporation, spray drying, and freeze drying exhibited higher dissolution characteristics than kneaded mixture, physical mixture, and pure oxatomide in distilled water.

Bottom Line: The coevaporated complex prepared in presence of PVP-K15 showed a prompt drug release and significantly increased % dissolution efficiency (P < 0.05) compared to the pure oxatomide.Moreover, the results of bioavailability evaluation of this complex in rabbits compared to commercial drug product indicated a 73.15% increase in the oral bioavailability of oxatomide.In conclusion, inclusion complex of oxatomide with β-cyclodextrin prepared by coevaporation in presence of PVP-K15 not only results in an enhancement of the oxatomide dissolution rate but also improves the bioavailability of oxatomide.

View Article: PubMed Central - PubMed

Affiliation: Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Helwan University, Cairo 11790, Egypt.

ABSTRACT
The objective of this study was to evaluate the influence of oxatomide β-cyclodextrin inclusion complex on the physicochemical properties and bioavailability of the drug. Oxatomide β-cyclodextrin solid complex was prepared with equimolar ratio of both oxatomide and β-cyclodextrin in presence or absence of water soluble polymers using different techniques. The coevaporated complex prepared in presence of PVP-K15 showed a prompt drug release and significantly increased % dissolution efficiency (P < 0.05) compared to the pure oxatomide. Moreover, the results of bioavailability evaluation of this complex in rabbits compared to commercial drug product indicated a 73.15% increase in the oral bioavailability of oxatomide. In conclusion, inclusion complex of oxatomide with β-cyclodextrin prepared by coevaporation in presence of PVP-K15 not only results in an enhancement of the oxatomide dissolution rate but also improves the bioavailability of oxatomide.

No MeSH data available.


Related in: MedlinePlus